600895 张江高科
2026/09 - 九个月
人民幣(K¥)
与去年同期
比较
2025/12
人民幣(K¥)
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
营业总收入2,169,7008.28%4,181,7311,983,3012,025,7381,906,719
减:营业总成本2,314,48721.76%3,419,4231,806,6141,546,1101,584,658
    其中:营业成本1,543,28828.09%2,147,316857,365849,930722,776
               财务费用433,68511.83%541,421521,809456,588420,670
               资产减值损失----17,58224(3,443)(4,747)
公允价值变动收益256,288-3,019.75%(335,478)803,623645,235531,567
投资收益435,545-37.43%672,692211,053205,936119,369
    其中:对联营企业和合营企业的投资收益(236,493)-148.87%323,620(98,602)(515,884)(40,711)
营业利润551,724-30.36%1,075,8321,229,3511,347,5031,000,503
利润总额551,262-30.47%1,267,9861,275,0791,311,856933,263
减:所得税费用196,319-6.99%292,016280,695371,210145,618
净利润354,943-38.98%975,970994,383940,646787,645
减:非控股权益(138,518)297.55%(10,152)11,962(7,254)(34,571)
股东净利润493,462-19.97%986,121982,422947,900822,216

市场价值指针
每股收益 (元) *0.310-18.42%0.6200.6300.6100.530
每股派息 (元) *0.064-11.11%0.2000.2000.1900.160
每股净资产 (元) *8.8602.84%8.8148.4628.0347.562
审计意见 #--标准无保留意见标准无保留意见标准无保留意见标准无保留意见
回页顶
备注: *未调整数据
#只提供简体内容